V617F mutations of the JAK2 gene in hematological neoplasms

被引：0
|
作者：
Mori, N. [1 ]
Yoshinaga, K. [1 ]
Tada, M. [1 ]
Wang, Y-H. [1 ]
Shiseki, M. [1 ]
Motoji, T. [1 ]
机构：
[1] Tokyo Womens Med Coll, Dept Hematol, Tokyo, Japan
来源：
EXPERIMENTAL HEMATOLOGY | 2006年 / 34卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
179F34
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [1] Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations
    Yang, Hai-Su
    CANCER BIOMARKERS, 2016, 17 (04) : 383 - 389
  • [2] Hematological relevance of JAK2 V617F and calreticulin mutations in Tunisian patients with essential thrombocythemia
    Abdelghani, Maroua
    Hammami, Haifa
    Zidi, Wiem
    Amouri, Hassiba
    Othmen, Hind Ben Hadj
    Farrah, Ahlem
    Menif, Samia
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (08)
  • [3] Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
    Gango, Ambrus
    Mozes, Reka
    Boha, Zsofia
    Kajtar, Bela
    Timar, Botond
    Kiraly, Peter Attila
    Kiss, Richard
    Fesus, Viktoria
    Nagy, Noemi
    Demeter, Judit
    Korosmezey, Gabor
    Borbenyi, Zita
    Marton, Imelda
    Szoke, Anita
    Masszi, Tamas
    Farkas, Peter
    Varkonyi, Judit
    Plander, Mark
    Posfai, Eva
    Egyed, Miklos
    Pal, Katalin
    Radvanyi, Gaspar
    Hamed, Aryan
    Csomor, Judit
    Matolcsy, Andras
    Alpar, Donat
    Bodor, Csaba
    LEUKEMIA RESEARCH, 2018, 65 : 42 - 48
  • [4] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
    Tanja Belcic Mikic
    Tadej Pajic
    Matjaz Sever
    Scientific Reports, 9
  • [5] JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms
    Choi, Daniel C.
    Abu-Zeinah, Ghaith
    Kermani, Pouneh
    Messali, Nassima
    Yabut, Maria Mia
    Erdos, Katie
    Scandura, Joseph M.
    BLOOD, 2023, 142
  • [6] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
    Mikic, Tanja Belcic
    Pajic, Tadej
    Sever, Matjaz
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Detection and interpretation of low level JAK2 V617F mutations
    Bryon, Jane
    Akiki, S.
    Griffiths, M.
    JOURNAL OF MEDICAL GENETICS, 2012, 49 : S46 - S46
  • [8] JAK2 mutations (V617F and exon 12) in children with erythrocytosis
    Randi, M. L.
    Scapin, M.
    Pacquola, E.
    Duner, E.
    Scandellari, R.
    Bonato, S.
    Putti, M. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 88 - 88
  • [9] JAK2, the JAK2 V617F mutant and cytokine receptors
    Staerk, J.
    Kallin, A.
    Royer, Y.
    Diaconu, C. C.
    Dusa, A.
    Demoulin, J.-B.
    Vainchenker, W.
    Constantinescu, S. N.
    PATHOLOGIE BIOLOGIE, 2007, 55 (02): : 88 - 91
  • [10] JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms
    Siemiatkowska, Anna
    Bieniaszewska, Maria
    Hellmann, Andrzej
    Limon, Janusz
    LEUKEMIA RESEARCH, 2010, 34 (03) : 387 - 389
12345